Prognosis of Acute Coronary Syndrome — MPCS-ACS  

Acute Coronary Syndrome Clinical Trial

Official title: A Multicenter, Prospective Cohort Study Evaluating the Prognosis of Patients With Acute Coronary Syndrome

Status Completed

Clinical Trial Summary

The MPCS-ACS Study (Multicenter Prospective Cohort Study on Acute Coronary Syndrome) is a comprehensive, forward-looking research project designed to understand the prognostic outcomes of patients diagnosed with acute coronary syndrome. Leveraging a multicenter approach, the study aims to collect data from a diverse group of patients, thereby enhancing the generalizability and relevance of its findings. Upon patient enrollment, a range of information will be carefully gathered, including demographic details, clinical history, and key biochemical markers. The study also intends to document the various medication regimens prescribed during hospital stays to evaluate their impact on patient outcomes. A pivotal aspect of MPCS-ACS is its thorough follow-up protocol, where patients are regularly monitored to track their recovery progress and the occurrence of any subsequent cardiovascular events after discharge. This methodical follow-up is designed to yield critical insights into the long-term prognosis of patients with acute coronary syndrome, ultimately aiding in the refinement of treatment approaches and elevating the standard of patient care across all participating centers.

Clinical Trial Description

The Multicenter Acute Coronary Syndrome Prognosis Cohort Study (MPCS-ACS) is an extensive, longitudinal research initiative designed to explore the prognostic outcomes of patients diagnosed with acute coronary syndrome (ACS) across various healthcare settings. This collaborative effort will involve numerous hospitals and aims to capture and analyze data from ACS patients admitted from June 1, 2016, to May 31, 2021. Data collection will encompass a wide array of variables, highlighting therapeutic interventions, biochemical markers pertinent to ACS and its management, alongside essential demographic and clinical history information. This initiative seeks to thoroughly understand the treatment dynamics for ACS during this timeframe and evaluate their efficacy. Follow-up procedures are integral to the MPCS-ACS, featuring routine evaluations every six months to a year after patients are discharged. These check-ins will employ both direct interactions and telecommunication to maintain a strong connection with participants, catering to those unable to visit the hospitals. This approach is designed to enhance participation rates and data quality, underpinning the study's credibility and the significance of its conclusions. With its comprehensive methodology and operational rigor, the MPCS-ACS aspires to shed light on the prognostic determinants and outcomes of ACS patients, ultimately aiming to refine patient care strategies and elevate treatment benchmarks within the domain of cardiovascular healthcare. ;

Related Conditions & MeSH terms

• Acute Coronary Syndrome
• Syndrome

• NCT number: NCT05164601
• Study type: Observational [Patient Registry]
• Source: Xinjiang Medical University
• Status: Completed
• Start date: June 1, 2016
• Completion date: December 31, 2023